What's the difference between semaglutide and tirzepatide?

Semaglutide is a single GLP-1 receptor agonist (Ozempic, Wegovy). Tirzepatide is a dual GLP-1 + GIP agonist (Mounjaro, Zepbound), and its dual mechanism appears to provide stronger metabolic effects for many users.

Which causes more weight loss, semaglutide or tirzepatide?

In trials, tirzepatide produced about 20–25% average body-weight loss versus about 15% for semaglutide. Results vary by individual, dose and consistency, so the better choice depends on your metabolic profile and tolerance.

Which is cheaper in India, semaglutide or tirzepatide?

Semaglutide is far cheaper after its Indian patent expired in March 2026 — generics run roughly ₹1,300–₹4,200/month. Tirzepatide remains patent-protected until about 2036 and costs roughly ₹13,125–₹25,781/month.

How do I decide between semaglutide and tirzepatide?

There's no universal winner — the right choice depends on your metabolic profile, goals, tolerance and budget. A doctor should evaluate your blood work, medical history and response rather than self-prescribing.

Semaglutide vs Tirzepatide: Which GLP-1 Medication Is Right for You?

The Two Giants of Modern Weight Loss Medicine

If you've been researching medical weight loss in 2025, two names dominate every conversation: semaglutide (branded as Ozempic and Wegovy) and tirzepatide (branded as Mounjaro and Zepbound). Both are GLP-1 receptor agonists. Both produce remarkable weight loss. But they are not identical — and understanding the differences matters when deciding which one is right for your body.

How They Work: The Science

Semaglutide mimics the GLP-1 hormone, suppressing appetite and slowing gastric emptying. Tirzepatide goes further — it's a dual agonist, targeting both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors. This dual mechanism appears to provide stronger metabolic effects in many users.

💉 Semaglutide

Single GLP-1 receptor agonist
~15% average body weight loss
Weekly subcutaneous injection
Established long-term safety data
Available as Ozempic / Wegovy

💊 Tirzepatide

Dual GLP-1 + GIP agonist
~20–25% average body weight loss
Weekly subcutaneous injection
Newer, rapidly growing evidence base
Available as Mounjaro / Zepbound

Which Should You Choose?

The honest answer: it depends on your metabolic profile, your goals, and how your body responds. Some users tolerate semaglutide better; others see dramatically better results on tirzepatide. This is exactly why self-prescribing based on Instagram posts is a bad idea — and why MetaFit's doctor-led evaluation process exists.

🩺 MetaFit's Approach

Our doctors evaluate your blood work, metabolic markers, and medical history before recommending a specific GLP-1 medication. No guesswork. No one-size-fits-all.

2026 Cost Update: The Price Picture Has Changed

Cost is now a major deciding factor. Since semaglutide's Indian patent expired in March 2026, generic versions have dropped its price to roughly ₹1,300–₹4,200/month, while tirzepatide (still patent-protected until ~2036) ranges from about ₹13,125 to ₹25,781/month. Dig into the details in our dedicated guides: generic semaglutide in India and Mounjaro cost in India 2026. New to GLP-1? Start with our complete GLP-1 weight loss guide.